potential (AP) bursts that occur during seizures without affecting normal neuronal activity (Rogawski and Loscher, 2004; Hille, 1977) .
Propofol (2,6-diisopropylphenol) , is most commonly known for its use as an intravenous general anesthetic; however, at sub-anesthetic doses, propofol is used clinically during refractory status epilepticus (RSE), a critical medical emergency with mortality rates as high as 76% in elderly patients (Claassen et al., 2002; Rossetti et al., 2004; Prasad et al., 2001; Marik and Varon, 2004) . Propofol has been shown to inhibit Na currents in mammalian cell lines expressing rat Na v 1.2 (Rehberg and Duch, 1999) , activate γ -aminobutyric acid (GABA) currents in hippocampal neurons (Orser et al., 1994) , and to inhibit L-type calcium currents in cortical neurons (Martella et al., 2005) .
However, its modulation of Na currents (Martella et al., 2005) has been suggested to be important for its AED activity in both veratridine-induced seizures and (Otoom and Hasan, 2004) amygdala-kindled rats (Borowicz and Czuczwar, 2003) . Although the mechanisms of action for propofol remains unclear, it continues to be an effective alternative to barbiturates and first-line AEDs when treating RSE (Rossetti et al., 2004) .
In this study, we have used propofol as a scaffold to design novel analogues. The first propofol analogue, 2-(3-Ethyl-4-hydroxy-5-isopropyl-phenyl)-3,3,3-trifluoro-2-hydroxy-propionamide (HS245), incorporates an α -hydroxyamide moiety we have previously shown to be important for Na channel inhibition (Brown et al., 1999; Lenkowski et al., 2004) . In a previous study, we have also shown that the replacement of one phenyl ring in the structure of phenytoin with a seven-carbon alkyl chain resulted in a potent and state-dependent Na channel blocker (Lenkowski et al., 2004) . To further determine the optimum distance between the phenyl and α -This article has not been copyedited and formatted. The final version may differ from this version.
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Downloaded from hydroxyamide moieties we designed 2-Hydroxy-8-(4-hydroxy-3,5-diisopropyl-phenyl)-2-trifluromethyl-octanoic acid amide (HS357), which incorporates a six-carbon alkyl linker (Fig 1) .
The effects of propofol, HS245, and HS357 were characterized on Na channel currents recorded from cultured hippocampal neurons and APs evoked in CA1 neurons from rat hippocampal slices. In an effort to optimize in vitro conditions for burst firing and epileptiform events, we employed a hyper-excitation model obtained by perfusing brain slices with a zero Mg 2+ / 7 mM K + artificial cerebrospinal fluid (ACSF) solution that allows a higher magnitude depolarization and a stronger excitatory response (Mangan and Kapur, 2004; Arias and Bowby, 2005) . In agreement with our in vitro studies, systemic administration of either propofol or HS357 protected mice from acute seizures observed in the 6Hz (22mA) partial seizure model; however, in contrast to propofol, the protection afforded by HS357 was not accompanied by motor impairment in the rotorod toxicity assay.
This article has not been copyedited and formatted. The final version may differ from this version.
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Materials and Methods
Materials. Propofol was obtained from Sigma-Aldrich (St. Louis, MO). 2-(3-Ethyl-4-
hydroxy-5-isopropyl-phenyl)-3,3,3-trifluoro-2-hydroxy-propionamide (HS245) and 2-Hydroxy-8-(4-hydroxy-3,5-diisopropyl-phenyl)-2-trifluromethyl-octanoic acid amide (HS357) were synthesized as described in the supplemental data (Supplemental Data HS245 Synthesis and Supplemental Data HS357 Synthesis).
Hippocampal Culture. All experimental protocols were approved by the Institutional Animal Care and Use Committee affiliated with the University of Virginia and the University of Utah. All efforts were made to minimize animal stress and discomfort. The preparation of hippocampal cultures has been previously described (Mangan and Kapur, 2004) . Briefly, hippocampi were dissected from 18-day-old rat embryos, dissociated by trypsin, and triturated with a Pasteur pipette. The neurons were plated on coverslips coated with poly-L-lysine in minimal essential medium (MEM), with 10% horse serum at an approximate density of 25,000/cm 2 . Once the neurons had attached to the substrate, they were transferred to a dish containing a glial monolayer and maintained for up to 4 weeks in serum-free MEM with N2 supplement. Voltage clamp recordings were made from 1-2 week-old cultured hippocampal neurons. Calcium and potassium currents were blocked by cadmium and TEA-Cl, respectively. On establishing the whole-cell configuration, neurons were held at -90 mV for 5 minutes to permit time for the equilibration of gating shifts. Currents were elicited from a holding potential of -90 mV by a step to -10 mV for 20 ms. Capacitive and leak currents were corrected for using standard P/4 protocols except during steady-state inactivation and use-dependent block protocols. All voltage clamp experiments were performed at room temperature (20-22 ºC). Current clamp recordings were performed at 32° C in an ACSF This article has not been copyedited and formatted. The final version may differ from this version. 
Brain Slice Preparation.
where C is the concentration, IC 50 is the concentration that blocks 50% of the current, I is the current in presence of the drug, I control is the current in the absence of drug, and n H is the Hill slope. Steady-state inactivation data were fitted to a Boltzman equation of the form:
where I/I max is the normalized current , I max is the maximum current, V 1/2 the voltage of half-maximal inactivation, and k is the slope factor. The difference between the V 1/2 value in the presence and absence of compound is shown as ∆ V 1/2 (mV).
This article has not been copyedited and formatted. The final version may differ from this version. The affinities for the inactivated states of the channel were calculated using the steady state inactivation curves in the presence of various concentrations of compound (Bean et al., 1983; Kuo and Bean, 1994) , according to the following equation:
where K i is the binding affinity for the inactivated state, K r is the binding affinity for resting state (calculated from dose-response curves at -90 mV), D is the drug concentration, k is the slope of the steady state inactivation curve and ∆ V 1/2 is the shift of the steady state inactivation curve in the presence of drug compared to control.
Time constants for recovery from inactivation were obtained using a double exponential function:
where A 1 and A 2 are the amplitudes of the fast and slow exponentials, t the time, and τ 1 and τ 2 the fast and slow time constants. The percentage of the current represented by the fast time constant was calculated from the equation:
Time constants for use-dependent block at 10 Hz were obtained using a single exponential function. experiments. Anticonvulsant activity was assessed using the 6 Hz partial 'psychomotor' seizure model described previously (Barton et al., 2001) . Briefly, seizure activity was evoked via corneal stimulation (6 Hz, 0.2 ms rectangular pulse width, 3 s duration, 22 mA) using a Grass S48 stimulator. A drop of 0.5% tetracaine anesthetic was applied directly to the eyes of all animals at the time of test compound administration. Tween 80 (not to exceed 1-2 drops) and/or dimethylsulfoxide (DMSO, <1% total volume) was used. Protection was defined as the absence of a seizure, while toxicity was defined as impairment of motor-coordination assessed in the rotorod assay. Impairment was defined as the inability of a mouse to maintain equilibrium in three consecutive trials during a one minute test on a rod rotating at 6 rpm. For each compound we evaluated the 
Results
Propofol and analogues block Na currents in hippocampal neurons.
The chemical structures of propofol, HS245 and HS357 are shown in Figure 1 .
We have previously shown that the replacement of the methyl group in themisone, an anticonvulsant used in the 1940s, with a tri-fluoro group yielded a compound with potent anticonvulsant activity in the maximal electric shock (MES) animal model of epilepsy (Choudhury-Mukherjee et al., 2003) (Fig 1) . In this study, we have continued to investigate the importance of both the tri-flouro and the α -hydroxyamide groups of this themisone analogue. While HS245 explores the functional consequences of overlapping the phenyl rings of propofol with our themisone analogue, HS357 explores the effects of separating the phenyl and the tri-flouro/α-hydroxyamide portions of HS245 with a sixcarbon alkyl linker (Fig 1) . Previous comparative molecular field analysis (CoMFA) modeling studies have suggested that compounds with longer alkyl chains have an increased affinity for the inactivated state of the cardiac Na channel (Lenkowski et al., 2004) . Interestingly, the structural changes made to the propofol scaffold resulted in different Log P, or lipophilicity values for propofol, HS245, and HS357 (3.63, 3.43, and 5.74, respectively) .
Propofol and derivates affinities for the inactivated state.
To determine the affinity for the resting state of the Na channel, concentration dependent curves were generated at a negative holding membrane potential of -90 mV (Fig 2) . When data were fit to the Hill equation, the IC 50 at -90 mV (K r ) values for propofol, HS245, and HS357 were 17.7 µ M, 100 µ M, and 24 µ M with corresponding Hill slopes of 0.98, 1.84, and 1.50, respectively (Fig 2A) . Interestingly, both HS245 and This article has not been copyedited and formatted. The final version may differ from this version. Figure 2B .
Propofol has previously been suggested to have a greater affinity for the inactivated state of the Na channel (Rehberg and Duch, 1999) . To test if HS245 and HS357 also demonstrated a similar affinity a two-pulse steady state inactivation protocol with a 1 s pre-pulse was used ( Figure 3A-C) . Under drug-free conditions, the voltage of half maximal inactivation (V 1/2 ) was -56.4 ± 1.1 mV with a slope value (k) of 5.6 ± 0.2 mV, (n=28). In a similar manner to propofol, HS245 caused a concentration dependent hyperpolarizing shift in V 1/2 . HS357 at the same concentrations caused a much greater shift in the V 1/2 (Table 1) . Slope factors (k) remained unchanged from those recorded in the absence of drug.
The affinity for the inactivated state of the channel for each compound was calculated from these concentration dependent shifts in steady-state inactivation and tonic block data using the equation described previously in the data analysis section (Fig 3 D ; Table 1 ). HS357 demonstrated a greater binding affinity for the inactivated state (K i = 0.2 µM) compared to propofol (K i = 0.7 µM) while HS245 had a lower binding affinity
Comparing the binding affinity to the resting state versus the inactivated state (K r /K i ) both HS245 and HS357 exhibited approximately a four to five-fold greater K r /K i ratio than the parent compound, propofol (Table 1) .
Propofol and analogues exhibit use-dependent block.
Use-dependent blocking characteristics are thought to be important since they allow further block of Na channels during sustained high-frequency depolarizations known to occur during seizure activity. To this end, use-dependent block of propofol and This article has not been copyedited and formatted. The final version may differ from this version. our compounds were examined using 10 Hz trains of depolarizing pulses to -10 mV from a holding potential of -90 mV (Fig 4) . Peak current amplitude was normalized to the first pulse in each experiment. Under control conditions, accumulation of inactivated channels resulted in a reduction in peak current amplitude by 30.4 ± 4.6% (n=16). Propofol and HS357 were both tested at 30 µM, a concentration close to their IC 50 's. At these concentrations propofol and HS357 further reduced the current amplitude by 60.8 ± 3.2%
(n=5), and 79.5 ± 6.6% (n=6), respectively (p < 0.01) after 6 seconds. Interestingly, when tested at a concentration lower than its IC 50 (30 µM), HS245 exhibited significant (p < 0.01) use-dependent block reducing the current amplitude to 50.7 ± 8.8% (n=5). To assess the rate of development of use-dependent block, data were fitted with a single exponential function. Time constants for propofol, HS245, and HS357 were 2 ± 0.2 s, 2.9 ± 0.7 s, and 1.6 ± 0.1 s, respectively.
Delay of recovery from inactivation.
Use-dependent block characteristics can arise from not only affinity for inactivated channels, but also from a delay in recovery from inactivation kinetics.
Therefore, we determined the effects of propofol, HS245, and HS357 on this parameter.
Recovery from inactivation was assessed using a two pulse protocol (Fig 5) . From a holding potential of -90 mV, a 1 s test pulse to 0 mV was applied, followed by a recovery step to -90 mV ranging from 1 ms to 100 s; currents were subsequently elicited by a second test pulse to -10 mV to assess recovery. In these experiments, compounds were assessed at a concentration close to their IC 50 values (i.e. 30 µM for propofol and HS357
and 100 µM for HS245). Data were normalized to the current amplitude during the first test pulse and fitted using a double exponential function. et al., 2006) . In the presence of all test compounds, both fast and slow time constants were increased indicating a slowing of recovery kinetics. This was coupled with a significant decrease in the proportion of channels recovering with a fast time constant. The greatest modulation of recovery kinetics was observed in the presence of HS357.
Propofol and HS357 modulate membrane excitability and epileptiform activity.
In comparison to HS245, HS357's actions on Na channel gating kinetics were more pronounced. In view of this, HS357 was selected to determine its effects on membrane excitability. The effects of propofol and HS357 on AP discharge and key parameters of the AP were determined. Under current clamp conditions, depolarizing current injections (0.02 -0.16 nA, 300 ms) were used to elicit AP discharges in CA1 neurons in hippocampal slices. Typical resting membrane potential (RMP) values for CA1 neurons under these recording conditions were -64.3 ± 2.4 mV (n =11) and remained unaltered in the presence of both propofol and HS357. The effects of propofol and HS357 on APs elicited after a 300 ms current injection of 0.14 nA are shown in Figure 6 . Both propofol and HS357 caused a modest reduction in the number of APs evoked. At a concentration of 30 µM, APs were reduced from 6.8 ± 1.2 to 4.3 ± 0.9 (n = 4, p < 0.05) for propofol and from 6.9 ± 1.6 to 4.9 ± 1.6 (n = 7, p < 0.05) for HS357.
These effects remained unchanged in the presence of picrotoxin (100 µM), a selective propofol nor HS357 altered input resistance, AP amplitude, AP duration, or afterhyperpolarization amplitude. In contrast to propofol, HS357 increased the rheobase by 20 pA (p < 0.05, n = 7, data not shown). All effects were fully reversible upon washout.
To test the effects of propofol and HS357 on sustained spontaneous ictal-like AP discharges, CA1 pyramidal neurons in hippocampal slices were perfused with ACSF containing zero Mg 2+ / 7 mM K + . The resulting enhanced neuronal excitability is thought to be comparable to epileptiform activity and is partially attributed to increased NMDA receptor activity as a result of reduced magnesium block (Mangan and Kapur, 2004) .
The perfusion of hippocampal slices (n = 9) with our modified ACSF solution (zero Mg 2+ / 7 mM K + ) resulted in sustained spontaneous discharges in CA1 pyramidal neurons (Fig. 7) . The number of APs spontaneously generated during a 100 s period prior to perfusion of the test compound was considered as control and was compared with the number of APs elicited in the presence of test compounds and following washout. Under control conditions, the average number of ictal discharges was 42.2 ± 6.5 (n = 9) and was reduced to 13.2 ± 2.7 in the presence of propofol (30 µM, n = 5, p < 0.01). After a 20 min period, only partial washout was observed for propofol (24.5 ± 5.0; Fig 7A) . In comparison, HS357 (30 µM, n = 4, p < 0.01) caused a further reduction in the number of epileptiform events reducing it to 8.8 ± 2.0, and was completely reversible after a 20 min washout (40.0 ± 15.6). Once again, the effects of HS357 were unaffected by the presence of picrotoxin (100 µM). Specifically, the number of APs counted in a 100 s interval prior to drug application was 118 ± 40 and was reduced to 19 ± 11 in the presence of both HS357 (30 µM) and picrotoxin (100 µM; p < 0.05, n = 3). Furthermore this effect, a 15.4
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Anticonvulsant activity and toxicity of propofol and HS357
To determine if the modulation of Na channel gating and decreased neuronal excitability observed in vitro would translate into anticonvulsant activity in vivo, test compounds were administered systemically to male CF-1 mice and tested in the 6 Hz (22 mA stimulation) partial psychomotor seizure model. Behavioral signs of toxicity were assessed using the mouse rotorod assay (Table 3) . A time of peak effect (TPE) of 1.0 hour for HS357 and approximately 5 minutes for propofol were determined following i.p.
administration of the compounds. At their respective TPE's, both propofol and HS357
prevented partial seizure activity in the 6 Hz test. The ED 50 observed following i.p.
administration of propofol (15.8 mg/kg) was 2.8-fold lower than that observed for HS357 (56.3 mg/kg). However, the protection afforded by propofol was associated with significant sedation and motor impairment, which resulted in a TD 50 of 18.0 mg/kg, consistent with propofol's anesthetic properties. In contrast, HS357 was observed to be profoundly less toxic, as indicated by its 9-fold higher TD 50 (155.7 mg/kg) than propofol.
The observed ED 50 and TD 50 values for propofol and HS357 resulted in estimated protective indices (PI) of 1.1 and 2.7, respectively. Taken together, these results demonstrate that HS357 not only exhibits anticonvulsant activity in the 6 Hz (22 mA) psychomotor seizure model, but also possesses fewer toxic side effects than propofol.
Discussion
Propofol at sub-anesthetic concentrations exhibits anticonvulsant properties in refractory status epilepticus patients (Brown and Levin, 1998; Prasad et al., 2001; Rossetti et al., 2004) . However, several studies have cautioned against the use of propofol as an anticonvulsant due to serious side effects (Claassen et al., 2002; Marik, 2004) . Although propofol is known to enhance GABA currents and inhibit Ca 2+ channels, its modulation of neuronal Na channels is thought to be a major determinant for its AED activity (Martella et al., 2005; Rehberg and Duch, 1999; Orser et al., 1994) . In this study, we have synthesized two novel analogues of propofol and characterized their effects on Na channel gating. One of the propofol derivatives, HS357, inhibited spontaneously generated APs and protected against seizures generated in 6 Hz (22 mA) psychomotor model with less behavioral toxicity than propofol.
Biophysical properties of propofol analogues parallel physicochemical and structural properties.
Propofol caused tonic inhibition of Na channel currents recorded from cultured hippocampal neurons with an IC 50 value of 17 µM, consistent with values reported for Na v 1.2 α -subunits expressed in CHO cells (Rehberg and Duch, 1999) . In contrast, addition of an α -hydroxyamide to the phenyl ring of propofol resulted in HS245 and a 5-fold lower affinity for the resting state but only a 1.6-fold difference in affinity for the inactivated state. Interestingly, HS357, which incorporates an alkyl linker between the amide and phenyl groups, exhibited a comparable resting state inhibition to that of propofol, but a 3.6-fold greater affinity for the inactivated state compared to propofol.
These distinct biophysical properties observed for propofol and its derivatives may
This article has not been copyedited and formatted. The final version may differ from this version. Ragsdale et al., 1996; Ragsdale and Avoli, 1998a; Yarov-Yarovoy et al., 2001) . In addition to these sites, it is also possible that the alkyl side chain of HS357 could form hydrophobic interactions sites with more distant residues such as L1465 and I1469 in D3-S6. These amino acids have also been suggested to form part of the AED and local anesthetic binding site (Yarov-Yarovoy et al., 2001) .
In fact, mutation of these residues to alanine decreased the affinity for the inactivated state for lamotrigine, its derivatives, and etidocaine (Yarov-Yarovoy et al., 2001; Ragsdale et al., 1994; Ragsdale et al., 1996; Yarov-Yarovoy et al., 2002) .
Finally, HS357 possesses a greater lipophilicity value (Log P), than propofol and
HS245. An increase in lipophilicity values may contribute to HS357's ability to readily form hydrophobic interaction within the AED binding site, consequently allowing stronger binding constants. Several studies have correlated increased Log P values with increased Na channel inhibition; indicating that hydrophobic interactions may be formed by Na channel blockers (Brown et al., 1997; De Luca et al., 2003; Yarov-Yarovoy et al., 2001 ).
Greater inhibition of epileptiform discharges by propofol analogue.
Under current clamp conditions, we determined the effects of propofol and in epileptic patients (Derchansky et al., 2004; Rafiq et al., 1995) . Furthermore, clinically used AEDs such as valproate, gabapentin, and carbamazepine have demonstrated efficacy in this in vitro hyperexcitability model (Arias and Bowby, 2005) . Both propofol and HS357 exhibited more pronounced block of epileptiform events than current-evoked APs. These results are consistent with previous studies showing selective inhibition by propofol of low Mg 2+ -induced epileptiform activity over current-evoked APs in cortical neurons (Martella et al., 2005) . In these studies, bicuculline abolished the effects of propofol on current-evoked APs, but not on low Mg 2+ -induced APs. In contrast, HS357's effects on both current-evoked APs and low Mg 2+ -induced APs were unchanged in the presence of picrotoxin, a selective GABA A antagonist, suggesting that HS357s actions
were not mediated by the potentiation of GABA currents. However, effects on other ion channel targets cannot be ruled out.
During spontaneous epileptic events, Na channels rapidly cycle through the closed, activated, and inactivated states. According to the modulated receptor hypothesis (Hille, 1977 ) Na channels accumulate in high affinity drug binding conformations (i.e.
open and/or inactivated states) and therefore the inhibitory effects of propofol and HS357 on epileptiform events may be explained by their greater affinities for the inactivated state. HS357's more pronounced inhibition of epileptic events compared to propofol could be attributed to its 4-fold greater K r /K i ratio than propofol, resulting in greater usedependent block and further delay of recovery from inactivation. These mechanisms would reduce Na channel availability during high-frequency repetitive firing (Ragsdale and Avoli, 1998b; Rogawski and Loscher, 2004) .
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In vivo studies and therapeutic implication for a novel propofol analogue. Our behavioral studies in the 6 Hz partial seizure model support our hypothesis that structural changes in the propofol scaffold can result in novel compounds with anticonvulsant activity. At efficacious doses (30 mg/kg), propofol caused marked sedation and ataxia, while HS357 (100 mg/kg) displayed little or no side effects at higher doses. The approximate 2-fold difference in protective index (PI) values for propofol and HS357 may again be attributed to HS357's far greater selectivity for the inactivated over resting state of the Na channel (i.e. K r /K i ratios). In other words, increased K r /K i ratios for Na channel blockers may indicate greater in vivo efficacy with fewer side effects by favoring block of sustained high-frequency firing, which is known to occur during epileptic activity, without interfering with normal neuronal firing.
The greater protective index of HS357 is a desirable characteristic for a potential AED and warranted in the therapeutic treatment of seizure suppression (Brodie, 2001) .
Equally important to improved tolerability is the identification of new AEDs with potential efficacy in therapy-resistance patients (Brodie, 2001) . Previous studies have implicated the use of the 6 Hz model (22-44 mA) for identifying potentially useful AEDs and differentiating those which may be effective for patients with therapy-resistant epilepsies (Barton et al., 2001) . For example, levetiracetam, an AED used to treat refractory human partial seizures, was effective in the 6 Hz model (22, 32, and 44 mA) but inactive in the maximal electroshock (MES) and subcutaneous metrazole (ScMET) seizure models (Barton et al., 2001) . Other anticonvulsant agents, including phenytoin, lamotrigine, and ethosuximide, were effective at blocking seizures in the 6 Hz model at 22 mA, but were unable to maintain this protection at 32 mA (phenytoin, lamotrigine) or This article has not been copyedited and formatted. The final version may differ from this version.
JPET Fast Forward. Published on as DOI: 10.1124 at ASPET Journals on July 7, 2017 jpet.aspetjournals.org Downloaded from at 44 mA (ethosuximide). Here, we show that HS357 is not only effective in the 6 Hz model at 22 mA, but also better tolerated than its parent compound, propofol. Given the activity identified at the 22 mA current intensity, it will be important to determine the potential utility of HS357 and/or propofol in the 6 Hz partial seizure model at higher current intensities in order to determine if these compounds would offer any potential benefit for refractory seizure activity. 
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